annual reports 
Producing and designing the annual reports for Pharming in compliance with ESEF requirements.
Since 2016, I have been designing and producing the Annual Report for Pharming. It is a complex annual report with a significant amount of photography, illustrations, and an extensive section of tables, narrating the story of the company. The report is available as a book, an interactive PDF, and in compliance with the European Single Electronic Format (ESEF). The first section is enriched with text, illustrations, and photography, resembling a magazine. The second part encompasses the financial overview of the annual figures.

Pharming Group N.V. is a Dutch publicly traded biotech company specializing in the development of innovative therapeutic proteins for challenging or difficult-to-treat diseases. The company's primary medication is RUCONEST®.

ESEF
Producing and designing the  annual reports for Pharming in compliance with ESEF requirements
 The entire Annual Report has been produced in the European Single Electronic Format (ESEF). Securities issuers are required to digitally publish their annual reports for financial years starting from January 1, 2021, in accordance with the European Single Electronic Format (ESEF) 
Back to Top